Follow Up Treatment | Stiolto® Respimat® Inhalation Spray | HCP
Population-based study of LAMA monotherapy effectiveness compared with LABA/ LAMA as initial treatment for COPD in primary care | npj Primary Care Respiratory Medicine
Asthma & COPD Medications Chart - National Asthma Council Australia
LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the d | COPD
JCM | Free Full-Text | Differences in Pulmonary Function Improvement after Once-Daily LABA/LAMA Fixed-Dose Combinations in Patients with COPD
Positioning of dual (LABA/LAMA) versus mono-LABD in the individualized... | Download Scientific Diagram
Effect of adding a LABA to a LAMA on FEV 1 in patients with COPD | Download Scientific Diagram
Approved fixed-dose combinations of LABAs and LAMAs for COPD treatment | Download Scientific Diagram
LAMA/LABA therapy reduced risk for COPD exacerbation, pneumonia hospitalization
Medical Treatment Algorithm for Chronic Obstructive ... | GrepMed
Frontiers | Single Inhaler LABA/LAMA for COPD
Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
Chronic Obstructive Pulmonary Disease: Diagnosis and Management | AAFP
American College of Chest Physicians - In a real-world setting, LAMA-LABA-ICS is as effective as LAMA-LABA to prevent COPD exacerbations, but incidence of pneumonia increased with triple therapy initiation: https://hubs.ly/H0pPLQ20 | Facebook
Real-World Adverse Reactions in COPD Patients on Inhaled Long-Acting Bronchodilators
Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: Cohort Study in Real-World Clinical Practice - ScienceDirect
Henna KD on X: "Inhaled steroids have been linked to increased pneumonia esp. n the elderly. We are moving towards LAMA+LABA combination inhalers for COPD. https://t.co/rJsiKkPnUU" / X
Cureus | Effect of Adding Inhaled Corticosteroid to Long-Acting Muscarinic Antagonist/Long-Acting Beta-Agonist Therapy Among Patients With Chronic Obstructive Pulmonary Disease
Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients? | Respiratory Research | Full Text
Long-acting maintenance pharmacotherapy in chronic obstructive pulmonary disease - ScienceDirect
DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling Approach | Advances in Therapy
A new alphabet for COPD care | European Respiratory Society
Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease ( COPD): Boon or Bane? | American Board of Family Medicine
Chronic Obstructive Pulmonary Disease: Diagnosis and Management | AAFP
